|
TUG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.595700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.673000E-01 |
| Normal-vs-Stage2 |
3.813400E-01 |
| Normal-vs-Stage3 |
8.307600E-01 |
| Normal-vs-Stage4 |
6.121200E-01 |
| Stage1-vs-Stage2 |
5.897800E-01 |
| Stage1-vs-Stage3 |
3.968800E-01 |
| Stage1-vs-Stage4 |
2.964200E-01 |
| Stage2-vs-Stage3 |
3.554600E-01 |
| Stage2-vs-Stage4 |
3.591600E-01 |
| Stage3-vs-Stage4 |
6.233400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023390E-01 |
| Normal-vs-AfricanAmerican |
4.385000E-01 |
| Normal-vs-Asian |
8.317600E-01 |
| Caucasian-vs-AfricanAmerican |
7.720800E-01 |
| Caucasian-vs-Asian |
8.162800E-01 |
| AfricanAmerican-vs-Asian |
9.139200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.662960E-01 |
| Normal-vs-Female |
8.750200E-02 |
| Male-vs-Female |
3.714200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.731800E-01 |
| Normal-vs-Extreme_Weight |
8.149000E-01 |
| Normal-vs-Obese |
5.555800E-02 |
| Normal-vs-Extreme_Obese |
9.924400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.798800E-01 |
| Normal_Weight-vs-Obese |
1.691020E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.372600E-01 |
| Extreme_Weight-vs-Obese |
1.038250E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.240000E-01 |
| Obese-vs-Extreme_Obese |
2.064400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.597640E-01 |
| Normal-vs-Age(41-60Yrs) |
5.358300E-03 |
| Normal-vs-Age(61-80Yrs) |
5.971800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.508580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.409200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.504000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.397600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.222200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.673770E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.770190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.804600E-04 |
| Normal-VS-Type2 PRCC |
4.441200E-03 |
| Normal-VS-KIRP CIMP |
3.971600E-01 |
| Normal-VS-Unclassified PRCC |
5.672600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.32830005170359E-09 |
| Type1 PRCC-VS-KIRP CIMP |
4.693000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.253400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.129800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.440800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.624000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.611200E-01 |
| Normal-vs-N1 |
2.588200E-01 |
| Normal-vs-N2 |
9.256000E-01 |
| N0-vs-N1 |
1.249020E-01 |
| N0-vs-N2 |
8.038600E-01 |
| N1-vs-N2 |
6.108800E-01 |
|
|
